Zeposia (ozanimod) Healthcare Professional Prescriber’s Checklist
This risk minimisation material is a condition of the marketing authorisation. The Prescriber's Checklist includes information on the ozanimod treatment initiation criteria (including re-initiation); monitoring parameters prior to, during and after treatment with ozanimod, counselling points for patients and pregnancy prevention for women of childbearing potential. Recent updates made to this material reflect changes made to the Summaries of Product Characteristics (SPCs) for ozanimod regarding dosing in patients with mild or moderate hepatic impairment (Child-Pugh class A or B).